Workflow
Cogent Biosciences (COGT) Soars 126% on Stomach Cancer Treatment Progress

We recently published 10 Market Movers That Made Millionaires in a Week. Cogent Biosciences, Inc. (NASDAQ:COGT) is one of the best-performing stocks of the past trading week. Cogent Biosciences skyrocketed by 126.3 percent week-on-week, as investor sentiment was boosted by the promising results of its last clinical trial that tested the efficacy of its drug candidate for a type of stomach cancer called Gastrointestinal Stromal Tumors (GIST). In an updated report, Cogent Biosciences, Inc. (NASDAQ:COGT) sa ...